St3Gal-II Antibodies

Santa Cruz Biotechnology features a diverse variety of St3Gal-II monoclonal antibodies for research focused on understanding this important glycosyltransferase. St3Gal-II Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).St3Gal-II, or ST3 beta-galactoside alpha-2,3-sialyltransferase 2, plays a crucial role in the biosynthesis of sialylated glycoconjugates, which are essential for cell-cell interactions, signaling, and immune responses. St3Gal-II has significant implications in cancer biology, as altered sialylation patterns can influence tumor progression and metastasis. Research into St3Gal-II function continues to reveal new insights about various pathological conditions and potential therapeutic targets. Studying St3Gal-II expression and activity helps advance understanding of cellular communication and disease mechanisms. Investigating St3Gal-II aids in uncovering new therapeutic strategies for cancer and other disorders. Exploring St3Gal-II's role in glycosylation pathways provides valuable information about cellular development and function. Santa Cruz Biotechnology monoclonal antibodies for St3Gal-II research support scientists worldwide in advancing our understanding of disease mechanisms and potential treatments.